BCBA/MRVL (BCBA/MRVL)

Buenos Aires Stock Exchange: BCBA/MRVL · ARS

ARS 29,760

+1020.26 (+3.5%)· Recorded snapshot

Market cap	339.3T
Revenue (ttm)	14.1T
Net income (ttm)	3.9T
EPS (ttm)	ARS 327
P/E (trailing)	90.9x
P/E (forward)	42.2x
Dividend	ARS 18.2 (0.06%)
Volume	11,330

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 14.1T
Net income (ttm): 3.9T
EPS (ttm): ARS 327
P/E (trailing): 90.9x
P/E (forward): 42.2x
Market cap: 339.3T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E42.2

P25 n/aP50 n/aP75 n/a

Trailing P/E90.9

P25 n/aP50 n/aP75 n/a

ROE16.5

P25 n/aP50 n/aP75 n/a

ROIC6.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BCBA/MRVL indicators

Market & fundamental data

Available fields

221

Groups with data

Currency

USD

Showing 221 of 221 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	ARS
Country	United States
Country code	AR
Earnings date	2026-12-03
Employees	7,480
Employees change	465
Employees growth	7.07%
Enterprise value	ARS 341.4T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-08-01
First seen	2026-05-10
Fiscal year end	January
Founded	1995
Industry	Semiconductors
Is primary listing	No
ISIN number	AR0557997514
Last earnings date	2026-08-27
Last refreshed	2026-10-29
Market cap	ARS 339.3T
Next earnings date	2026-12-03
Price	ARS 29,760.00
Price currency	ARS
Sector	Technology
SIC code	3674
Stock price date	2026-10-28
Symbol	bcba/MRVL
Website	https://www.marvell.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	1.1%
EV/Earnings	86.81x
EV/EBIT	139.75x
EV/EBITDA	75.79x
EV/FCF	132.46x
EV/Sales	23.49x
FCF / EV yield	0.75%
FCF yield	0.76%
Forward P/E	42.19x
Graham number	4334.78766
Graham upside	-85.43%
P/(FCF - SBC) ratio	252.75x
P/(OCF - SBC) ratio	166.09x
P/B ratio	12.29x
P/E ratio	90.91x
P/FCF ratio	131.65x
P/OCF ratio	103.52x
P/S ratio	24.1x
Price / tangible book value	110.88x
Price/EBITDA ratio	79.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	16.81%
EBITDA margin	30.16%
Effective tax rate	13.69%
FCF margin	17.71%
Gross margin	52.22%
Operating margin	16.81%
Pretax margin	32.37%
Profit margin	27.93%
Profit per employee	ARS 525.7M
Profitable quarters	7
Profitable years	1
Revenue per employee	ARS 1.9B
ROA	4.13%
ROA (5Y)	0.71%
ROCE	6.34%
ROE	16.52%
ROE (5Y)	0.47%
ROIC	6.94%
ROIC (5Y)	0.08%
SBC / revenue	8.77%
Tax / revenue	4.43%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (Q)	50%
EPS growth (QoQ)	743.67%
EPS growth quarters	1
EPS growth years	2
FCF growth	12.81%
FCF growth (Q)	15.62%
FCF growth (QoQ)	-0.89%
FCF growth 3Y	30.65%
FCF growth 5Y	27.34%
Gross profit growth	37.54%
Gross profit growth (Q)	44.03%
Gross profit growth 3Y	24.58%
Gross profit growth 5Y	22.74%
Net income growth (Q)	58.11%
Net income growth (QoQ)	792.75%
Net income growth quarters	1
Net income growth years	2
OCF growth	19.27%
OCF growth (Q)	31.17%
OCF growth (QoQ)	-5.21%
OCF growth 3Y	26.64%
OCF growth 5Y	28.66%
Operating income growth	100.3%
Operating income growth (Q)	52.91%
Revenue growth	30.62%
Revenue growth (Q)	36.55%
Revenue growth (QoQ)	13.3%
Revenue growth 10Y	15.05%
Revenue growth 3Y	18.93%
Revenue growth 5Y	22.28%
Revenue growth quarters	8
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	ARS -700.4B
Depreciation and amortization	ARS 1.9T
EBIT	ARS 2.4T
EBITDA	ARS 4.2T
EPS	ARS 327.37
Financing cash flow	ARS -311.8B
Free cash flow	ARS 2.6T
Free cash flow minus SBC	ARS 1.3T
Gross profit	ARS 7.4T
Income taxes	ARS 623.7B
Investing cash flow	ARS 1.1T
Net borrowing	ARS 768.2B
Net cash flow	ARS 4T
Net income	ARS 3.9T
Operating cash flow minus SBC	ARS 2T
Operating income	ARS 2.4T
Revenue	ARS 14.1T
Stock-based compensation	ARS 1.2T

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	7.97
Book value per share	ARS 31,481.32
Debt / EBITDA	1.8
Debt / equity	0.29
Debt / FCF	3.06
Goodwill	ARS 21.4T
Interest coverage	7.34
Long-term assets	ARS 28.8T
Long-term liabilities	ARS 9.6T
Net cash (debt)	ARS -2T
Net cash / market cap	-0.59%
Net debt / EBITDA	0.47
Net debt / equity	0.07
Net debt / FCF	0.78
Piotroski F-Score	6
Property, plant and equipment	ARS 2.1T
Shareholders' equity	ARS 27.6T
Tangible book value	ARS 3.1T
Tangible book value per share	ARS 3,489.66
Total assets	ARS 41T
Total cash	ARS 5.9T
Total debt	ARS 7.9T
Total liabilities	ARS 13.4T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.39
Current assets	ARS 12.2T
Current liabilities	ARS 3.8T
Current ratio	3.17
Inventory turnover	3.74
Net working capital	ARS 2.3T
Quick ratio	2.46
Working capital	ARS 8.1T
Working capital turnover	3,737.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-2.56%
Dividend growth	39.58%
Dividend growth years	1
Dividend payment date	2026-10-29
Dividend payment years	3
Dividend payout frequency	Quarterly
Dividend per share	ARS 18.25
Dividend yield	0.06%
Ex-dividend date	2026-10-09
Last dividend	ARS 6.51
Payout ratio	7.93%
Shareholder yield	-2.49%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	ARS 23,764.80
1D price change	3.55%
1M price change	-2.04%
1M total return	-2.02%
1W price change	5.98%
1W total return	5.98%
1Y price change	212.44%
1Y return CAGR	213.03%
1Y total return	212.78%
20-day SMA	ARS 29,550.00
200-day SMA	ARS 20,001.90
3M price change	37.52%
3M total return	37.55%
50-day SMA	ARS 27,977.00
50-day SMA vs 200-day SMA	50over200
52-week high	ARS 35,780.00
52-week high date	2026-06-19
52-week low	ARS 7,540.00
52-week low date	2026-02-04
6M price change	73.63%
6M total return	73.69%
All-time high	ARS 35,780.00
All-time high date	2026-06-19
All-time low	ARS 3,800.00
All-time low date	2025-04-21
Average true range (ATR)	ARS 1,698.97
Average volume	28.3K
Change from 52-week high	-16.83%
Change from 52-week low	294.7%
Change from all-time high	-16.83%
Change from all-time low	683.16%
Change from open	1.99%
Day's gap	1.53%
Dollar volume	ARS 337.2M
High price	ARS 30,120.00
Low price	ARS 29,080.00
Monthly RSI	68.66
Open price	ARS 29,180.00
Position in 52-week range	65.38%
Previous close	ARS 28,740.00
Price vs 150-day SMA	25.23%
Price vs 20-day SMA	0.71%
Price vs 200-day SMA	48.79%
Price vs 50-day SMA	6.37%
Relative volume	0.4
RSI	54.48
Sharpe ratio	1.77
Sortino ratio	3.07
Volume	11.3K
Weekly RSI	60.53
YTD price change	215.42%
YTD total return	215.77%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	873.8M
Shares change (QoQ)	3.12%
Shares change (YoY)	2.56%
Shares held by insiders	0.18%
Shares held by institutions	81.11%
Short ratio	1.2 days

Deeper analysis on BCBA/MRVL

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BCBA/MRVL report

Is a complete BCBA/MRVL research report available?

No complete published report is available for bcba/MRVL (BCBA/MRVL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/MRVL (BCBA/MRVL)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/MRVL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/MRVL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/MRVL

Frequently asked questions